Some one seems to think investors don't read past the first line re FDA pending minutes. In my view SI has covered the topic very well and has left share holders with facts and no fiction.
Now to a small detail that may seem rather minor however sector seems to be concerned about even after the announcements. JCR royalties have increased , have they got there new manufacturing facility up and running or have they simply run another batch through the old process? Good work JCR.
Ann: Novartis and Mesoblast Remestemcel-L Collaboration, page-345
-
- There are more pages in this discussion • 467 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.0¢ |
Change
-0.020(2.08%) |
Mkt cap ! $1.073B | |||
| Open | High | Low | Value | Volume |
| 95.5¢ | 97.0¢ | 93.5¢ | $1.424M | 1.507M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 29390 | 93.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 14089 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |